CYCLERION THERAPEUTICS, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$2M
R&D
$959K
D&A
—
Operating Income
$-5M
EBITDA
$-5M
Other Income/Expense
$1M
Pretax Income
$-4M
Tax Provision
$0
Net Income
$-4M
Operating Margin
-239.8%
Net Margin
-170.1%
Effective Tax Rate
0.0%
Deferred Tax Assets
$0
Deferred Tax Liabilities
—
DTA Valuation Allowance
$83M
Tax Credit Carryforwards
$10M
NOL Carryforwards
$58M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost
—
Revenue YoY Variation
3.7%
Income YoY Variation
-37.1%